During the past decade, Hôpital Saint-Eloi - Hématologie Clinique conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Saint-Eloi - Hématologie Clinique" #1 collaborator was "Acute Leukemia French Association" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BeiGene" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Saint-Eloi - Hématologie Clinique" are "Acute Myeloid Leukemia" (5 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloblastic Leukemia" (1 trials), "Bruton Tyrosine Kinase Inhibitor" (1 trials) and "CLL, Refractory" (1 trials). Many other conditions were trialed in "Hôpital Saint-Eloi - Hématologie Clinique" in a lesser frequency.

Most popular intervention types in "Hôpital Saint-Eloi - Hématologie Clinique" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "ACA Continuation" (1 trials), "Blinatumomab" (1 trials), "CPX-351" (1 trials) and "Chemotherapy (Induction Period)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Saint-Eloi - Hématologie Clinique" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital Saint-Eloi - Hématologie Clinique". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hôpital Saint-Eloi - Hématologie Clinique, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Saint-Eloi - Hématologie Clinique, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".